Newly Diagnosed Multiple Myeloma (NDMM) Clinical Trials in Bruges, West-Vlaandere

Positron Emission Tomography With Innovative Laboratory Techniques for Improved Risk and Disease Assessment in Newly Diagnosed Multiple Myeloma Patients